| Bupropion for amphetamine withdrawal syndrome. | |
| | |
MedLine Citation:
|
PMID: 11999825 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This study was a case report of an amphetamine abuser who came to see doctor because of amphetamine withdrawal syndrome three days after stopping prolonged use of amphetamine. The patient was treated him with a slow-release bupropion at the dose of 150 mg per day. After taking bupropion, his withdrawal symptoms i.e. dysphoric mood, fatigue, somnolence, and psychomotor retardation gradually disappeared within two to three days. Moreover, his craving for amphetamines was absent. The authors discussed the possible application for the clinical use for amphetamine abusers or dependence. |
| | |
Authors:
|
T Chan-Ob; N Kuntawongse; V Boonyanaruthee |
Related Documents
:
|
6818595 - Feeding stimulated by very low doses of d-amphetamine administered systemically or by m... 6440155 - The effects of thyrotropin releasing hormone on a visual discrimination task in rats. 6775335 - Continuous-access phencyclidine self-administration by rhesus monkeys leading to physic... 2672405 - Behavioral teratogenic effect of methylmercury and d-amphetamine: meta-analysis and pow... 23636065 - Modulating autophagy improves cardiac function in a rat model of early-stage dilated ca... 6818595 - Feeding stimulated by very low doses of d-amphetamine administered systemically or by m... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of the Medical Association of Thailand = Chotmaihet thangphaet Volume: 84 ISSN: 0125-2208 ISO Abbreviation: J Med Assoc Thai Publication Date: 2001 Dec |
Date Detail:
|
Created Date: 2002-05-09 Completed Date: 2002-06-10 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7507216 Medline TA: J Med Assoc Thai Country: Thailand |
Other Details:
|
Languages: eng Pagination: 1763-5 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Thailand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Amphetamine / adverse effects* Antidepressive Agents, Second-Generation / therapeutic use* Bupropion / therapeutic use* Humans Male Substance Withdrawal Syndrome / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents, Second-Generation; 300-62-9/Amphetamine; 34841-39-9/Bupropion |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of...
Next Document: A family at risk of congenital adrenal hyperplasia: a molecular approach for prenatal diagnosis.